Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains
about
Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cellsThe sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanismThe inhibition of Platycodin D on Mycoplasma pneumoniae proliferation and its effect on promoting cell growth after anti-Mycoplasma pneumoniae treatmentFibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis.Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation.Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism.In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.A multi-laboratory profile of Mycoplasma contamination in Lawsonia intracellularis culturesCPAF: a Chlamydial protease in search of an authentic substrate.Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion.Temporal expression of type III secretion genes of Chlamydia pneumoniae.Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma.Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome.Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.Andrographolide inhibits intracellular Chlamydia trachomatis multiplication and reduces secretion of proinflammatory mediators produced by human epithelial cells.Comparative analysis of the growth and biological activity of a respiratory and atheroma isolate of Chlamydia pneumoniae reveals strain-dependent differences in inflammatory activity and innate immune evasion.Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine modelChlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).Simultaneous detection and identification of common cell culture contaminant and pathogenic mollicutes strains by reverse line blot hybridizationSignaling events in pathogen-induced macrophage foam cell formation.Induction and inhibition of CPAF activity during analysis of Chlamydia-infected cells.Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.Interaction between components of the type III secretion system of Chlamydiaceae.Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells.Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNAExperimental infection of BHK21 and Vero cell lines with different Mycoplasma spp.Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting p38 MAPK Signaling.A single-tube real-time PCR assay for Mycoplasma detection as a routine quality control of cell therapeutics.Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis.MTOR inhibitor-based combination therapies for pancreatic cancer.Elimination of Mycoplasma contamination in Chlamydia stocks as a result of in vivo passage or plaque isolation.
P2860
Q24798576-D59784AC-7F0D-415E-94BD-A1DB99A04F86Q27333845-694AD64D-94D7-479A-9D66-0211F2BE8834Q28652297-91993E9A-E057-4BEC-8FDC-CBB1DD6D1C40Q33624326-E308720D-7861-479D-B99F-88A2DE2DE045Q33635225-DAC2C8A8-6915-4314-B956-A7F2E73F9F0FQ33939260-7D877957-89EC-4A58-BD74-0AEF18F97973Q33965613-FC9F09E2-AF62-4812-94C3-B20148F72A84Q33969754-DE3D5F22-E4B4-42AB-ACBE-CB1A5E113ED5Q34141733-DE2239C2-3455-49B5-ABE5-729FCE36AA13Q34143226-C24559EB-556F-4DAC-ABEE-BBDF73C8337FQ34372321-E20E0F73-DF47-4F0C-80AA-5C695BA0CF04Q34757680-761523EE-1A5C-434F-B8F5-4682567390B7Q34935390-09EEB5FE-C79F-4F11-8BC1-103A17BB7E81Q35106297-9CCA469B-1A42-4452-93FE-D8E947DCEE47Q35164422-E4BA2DF2-2FEA-4863-AB0C-97E30221E393Q35841813-43195272-FFFB-45D7-A56B-E9AFCFBA2279Q35975515-4EF87106-288E-4662-88F3-352C3128ABE2Q36202987-950C5F6F-50A7-4144-A787-65030439AA46Q36698167-DFEDA4A7-C34B-4E29-9EDE-EF92D2009DAEQ36703071-57356F94-FA51-4587-8A6B-BB97D624BBB9Q36930587-E02F9CB1-B8A6-4CA7-948C-B462CC84432AQ37835915-E5020A0A-A283-4720-B8AD-E13341DECA1BQ37841976-2928487D-8232-477B-8468-639E34799BD1Q37859892-EA5BF8B0-4165-453C-B795-4739E9613A26Q37862482-74C41420-D2C0-4FC2-8C70-8EE7EA820D4EQ37865819-4A76E452-05B0-463D-A7DF-AC79AECC864AQ37869400-9FFA084B-A96D-41BA-A66C-23C99F437BADQ37872148-478A3107-65C7-4C50-9639-50F6B7DA625BQ37876764-BE764747-12A5-49FE-B469-862DD692B2EEQ39039329-4A8B1394-D917-4316-988D-C080A73D9C46Q40156244-FFEB1AB3-ACE9-4115-B605-2731128B3232Q41957908-C9BCFEBB-21D4-441C-AC32-C1AC8E8C0A99Q47172400-26070E8B-BC94-4DBD-9492-A8C0C9D49B0EQ49560871-9B7440DA-238C-4306-8058-D4C7B85AD353Q55251090-E204F86B-AF3A-4173-9F34-E9CAF3C8CFD9
P2860
Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@ast
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@en
type
label
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@ast
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@en
prefLabel
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@ast
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@en
P2093
P2860
P1476
Application of a Mycoplasma gr ...... infected Chlamydia sp. strains
@en
P2093
Bestebroer T
Ossewaarde JM
de Vries A
P2860
P304
P407
P577
1996-02-01T00:00:00Z